Skip to content

Assessing intestinal inflammation in Crohn’s disease using ultrasound and an index value

Calculating the Lemann Index using Intestinal Ultrasound (EXTENT) - Calculating the Lemann Index Using Intestinal Ultrasound (EXTENT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58469
Enrollment
6
Registered
2025-05-23
Start date
2025-12-15
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease inflammatory bowel disease

Interventions

No investigational product and/or intervention is being investigated or used as a control in this study.

Sponsors

International Bowel Ultrasound Group e.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any Screening procedures.Patients with a previously documented Crohn's disease diagnosis confirmed by clinical, endoscopic, histological, and/or radiological criteria.Age =18 years old.Examinations needed as standard of care.

Exclusion criteria

Exclusion criteria: Pregnancy and female patients of child-bearing potential planning a pregnancy during the study periodPatients with a primary diagnosis of ulcerative colitis or IBD unclassified or microscopic colitis Patients with disease limited to the upper GI tract, rectum or perianal CDPatients with a contraindication for MR, colonoscopy and/or ultrasoundPatients with allergy to gadolinium chelated or with eGFR<60 mL/min/1.73m2Patients unwilling or unable to provide informed, written consent.

Design outcomes

Primary

MeasureTime frame
Difference between the LI-IUS scores and the LI-MRE scores assessing small bowel damage and colon damage in patients with CD.

Secondary

MeasureTime frame
Difference between the LI-IUS scores and the LI-MRE and colonoscopy scores in assessing colon damage in patients with CD.Difference between the LI-IUS and LI-MRE segmental damage scores (terminal ileum) and LI-IUS and LI-MRE+colonoscopy (all colonic segments, except rectum).Difference between the small bowel, colon and global LI-IUS and LI-MRE scores by local investigators and central readers.Acceptability rate of IUS, MRE and colonoscopy.Difference between the evaluations of small bowel and colon LI-IUS damage scores between central readers.Difference between the evaluations of small bowel and colon LI-MRE damage scores between central readers.Difference between repeated evaluations of small bowel and colon LI-IUS damage scores by central readers.Differencen between repeated evaluations of small bowel and colon LI-MRE damage scores by central readers.Difference between IBD disability index and small bowel and colon damage scores, as evaluated by IUS or by MRE.Difference between IUS and MRE for the presence and distribution of stricturing and penetrating lesions by central readers.

Countries

Belgium, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom, United States

Contacts

Public ContactSR Royo

International Bowel Ultrasound Group e.V.

extent@bowel-ultrasound.org+491737038223

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 3, 2026